Phase II study of weekly docetaxel in patients with metastatic breast cancer.

@article{Aihara2002PhaseIS,
  title={Phase II study of weekly docetaxel in patients with metastatic breast cancer.},
  author={Tomohiko Aihara and Young Chul Kim and Yuichi Takatsuka},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2002},
  volume={13 2},
  pages={286-92}
}
BACKGROUND This study was conducted to investigate the efficacy and toxicity of weekly docetaxel administration in patients with metastatic breast cancer. PATIENTS AND METHODS Thirty-seven women were treated with 1 h infusions of docetaxel at 40 mg/m2/week after pre-medication with 8 mg dexamethazone. Each cycle consisted of three consecutive weekly treatments followed by a 1 week rest. All patients were assessed for toxicity; five patients were not assessable for clinical response, time to… CONTINUE READING